Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective

Hirokuni BeppuAdministrative Director of NPO DIPEx-Japan, Yokohama SOWA Clinic, Physician, Kanagawa, Japan,. [email protected]Masumi MinaguchiAttorney at law, Santama Law Firm, Secretary-General, Medwatcher Japan, Tokyo, Japan,. [email protected]Kiyoshi UchideSpecial Professor, Health Information Management Stage, Komatsu College, Ishikawa, Japan,. [email protected]Kunihiko KumamotoProfessor, Department of Mass Communication, College of Media and Communication, Edogawa University, Chiba, Japan,. [email protected]Masato SekiguchiAttorney at Law, Kashinoki Law Firm, Tokyo, Japan,. [email protected]Yukari YajuAssociate Professor, Nursing Statistics, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan,. [email protected]
ABI

Аннотация

The human papillomavirus (HPV) vaccine has been linked to a number of serious adverse reactions. The range of symptoms is diverse and they develop in a multi-layered manner over an extended period of time. The argument for the safety and effectiveness of the HPV vaccine overlooks the following flaws: (i) no consideration is given to the genetic basis of autoimmune diseases, and arguments that do not take this into account cannot assure the safety of the vaccine; (ii) the immune evasion mechanisms of HPV, which require the HPV vaccine to maintain an extraordinarily high antibody level for a long period of time for it to be effective, are disregarded; and (iii) the limitations of effectiveness of the vaccine. We also discuss various issues that came up in the course of developing, promoting and distributing the vaccine, as well as the pitfalls encountered in monitoring adverse events and epidemiological verification.

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар

0 та иқтибос0 та фойдаланилган манба